Moleculin Biotech Inc.

NASDAQ: MBRX · Real-Time Price · USD
0.67
0.02 (3.43%)
At close: Aug 15, 2025, 3:59 PM
0.69
2.85%
After-hours: Aug 15, 2025, 07:43 PM EDT

Moleculin Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-21.76M -29.77M -29.02M -15.89M
Depreciation & Amortization
126K 127K 130K 164K
Stock-Based Compensation
1.73M 1.98M 2.27M 2.37M
Other Working Capital
699K 1.22M -507K 803K
Other Non-Cash Items
-4.18M 1.94M -1.24M 96K
Deferred Income Tax
n/a n/a n/a -6.73M
Change in Working Capital
231K 1.62M 224K 1.04M
Operating Cash Flow
-23.86M -24.1M -27.64M -18.95M
Capital Expenditures
-13K -124K -67K -19K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-13K -124K -67K -19K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a -23K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-25K 485K n/a 40K
Financial Cash Flow
4.63M 4.65M -23K 74.72M
Net Cash Flow
-19.27M -19.59M -27.76M 55.73M
Free Cash Flow
-23.88M -24.23M -27.71M -18.97M